Robotic Radiotherapy Market

Siemens Healthineers AG (Germany) and Elekta (Sweden) are Leading players in the Robotic Radiotherapy Market

The global robotic radiotherapy market is projected to reach USD 1.9 billion by 2028 from USD 1.1 billion in 2023, growing at a CAGR of 11.9% during the forecast period. The growing use of the robotic radiotherapy market for cancer treatment is propelled by increasing adoption driven by technological advancements and a rising prevalence of cancer. Growing demand for non-invasive treatments further fuels this growth. Additionally, increased healthcare expenditure in developing countries, coupled with government and private investments, bolster the adoption of radiotherapy. However, challenges such as inadequate healthcare infrastructure, high costs associated with robotic radiotherapy, technological complexity, and a shortage of skilled radiologists are anticipated to impede market growth in the forecast period.

The robotic radiotherapy  business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global robotic radiotherapy  market are Siemens Healthineers AG (Germany), Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), and ViewRay, Inc. (US), among others.

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers AG (Germany)

In 2022, Siemens Healthineers AG became the leading player in the robotic radiotherapy market after the successful acquisition of Varian Medical Systems, Inc. (US) in April 2021. To expand its geographical footprint, the company emphasizes both organic and inorganic growth strategies. A strong focus on the expansion of R&D activities in the areas of artificial intelligence (AI), robotics, and sensing technology,  has enabled the company to introduce novel products. Varian medical systems, Inc., under Siemens Healthineers, has introduced and received regulatory approvals for the ProBeam proton therapy system, ProBeam 360 with multi-room configuration, and Halcyon system.

Siemens Healthineers AG, through Varian Medical Systems, Inc., has also entered into several agreements, partnerships, collaborations, and contracts during the last three years to enhance its market presence. These deals have helped the company strengthen its position in the global robotic radiotherapy market.

Elekta (Sweden)

In 2022, Elekta will be another leading players in the robotic radiotherapy market, including products and services. The company has a strong brand presence in North America, Europe, and Asia(especially in China, India, and East Asia. Elekta has established its direct presence in the Philippines and Indonesia to gain a larger market share in the Asian market. The company also has an established custom services support setup, which helps it strengthen customer relationships and its presence in the robotic radiotherapy market.

Elekta provides its radiotherapy products to more than 6,000 hospitals and cancer research institutes worldwide, and the company has installed a base of 7,150 radiotherapy devices, of which about 5,250  wereLINAC systems by the end of 2022. The demand for Elekta’s products is high among end users owing to their high quality and strong brand image.

Related Reports:

Robotic Radiotherapy Market by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Robotic Radiotherapy Market Size,  Share & Growth Report
Report Code
MD 8992
RI Published ON
4/12/2024
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status